Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

In search of a counter you can count on: relative efficacy of human visual and automated colony counting.

Young LM, Rieman DJ, Walden L, Motz VA.

Lett Appl Microbiol. 2018 Mar;66(3):188-193. doi: 10.1111/lam.12851. Epub 2018 Feb 2.

PMID:
29341168
2.

Phenylbutyrates as potent, orally bioavailable vitronectin receptor (integrin alphavbeta3) antagonists.

Miller WH, Manley PJ, Cousins RD, Erhard KF, Heerding DA, Kwon C, Ross ST, Samanen JM, Takata DT, Uzinskas IN, Yuan CC, Haltiwanger RC, Gress CJ, Lark MW, Hwang SM, James IE, Rieman DJ, Willette RN, Yue TL, Azzarano LM, Salyers KL, Smith BR, Ward KW, Johanson KO, Huffman WF.

Bioorg Med Chem Lett. 2003 Apr 17;13(8):1483-6.

PMID:
12668017
3.

Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production.

Kumar S, Hanning CR, Brigham-Burke MR, Rieman DJ, Lehr R, Khandekar S, Kirkpatrick RB, Scott GF, Lee JC, Lynch FJ, Gao W, Gambotto A, Lotze MT.

Cytokine. 2002 Apr 21;18(2):61-71.

PMID:
12096920
4.

Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family.

Motyckova G, Weilbaecher KN, Horstmann M, Rieman DJ, Fisher DZ, Fisher DE.

Proc Natl Acad Sci U S A. 2001 May 8;98(10):5798-803. Epub 2001 May 1.

5.

IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase.

Kumar S, Votta BJ, Rieman DJ, Badger AM, Gowen M, Lee JC.

J Cell Physiol. 2001 Jun;187(3):294-303.

PMID:
11319753
6.

Biosynthesis and processing of cathepsin K in cultured human osteoclasts.

Rieman DJ, McClung HA, Dodds RA, Hwang SM, Holmes MW, James IE, Drake FH, Gowen M.

Bone. 2001 Mar;28(3):282-9.

PMID:
11248658
7.

Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized rat.

Lark MW, Stroup GB, Dodds RA, Kapadia R, Hoffman SJ, Hwang SM, James IE, Lechowska B, Liang X, Rieman DJ, Salyers KL, Ward K, Smith BR, Miller WH, Huffman WF, Gowen M.

J Bone Miner Res. 2001 Feb;16(2):319-27.

8.

SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung.

Underwood DC, Osborn RR, Bochnowicz S, Webb EF, Rieman DJ, Lee JC, Romanic AM, Adams JL, Hay DW, Griswold DE.

Am J Physiol Lung Cell Mol Physiol. 2000 Nov;279(5):L895-902.

9.

Identification and cloning of a human urea transporter HUT11, which is downregulated during adipogenesis of explant cultures of human bone.

Prichett WP, Patton AJ, Field JA, Brun KA, Emery JG, Tan KB, Rieman DJ, McClung HA, Nadeau DP, Mooney JL, Suva LJ, Gowen M, Nuttall ME.

J Cell Biochem. 2000 Jan;76(4):639-50.

PMID:
10653983
10.

Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis.

Badger AM, Griswold DE, Kapadia R, Blake S, Swift BA, Hoffman SJ, Stroup GB, Webb E, Rieman DJ, Gowen M, Boehm JC, Adams JL, Lee JC.

Arthritis Rheum. 2000 Jan;43(1):175-83.

11.

Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic.

Miller WH, Alberts DP, Bhatnagar PK, Bondinell WE, Callahan JF, Calvo RR, Cousins RD, Erhard KF, Heerding DA, Keenan RM, Kwon C, Manley PJ, Newlander KA, Ross ST, Samanen JM, Uzinskas IN, Venslavsky JW, Yuan CC, Haltiwanger RC, Gowen M, Hwang SM, James IE, Lark MW, Rieman DJ, Stroup GB, Azzarano LM, Salyers KL, Smith BR, Ward KW, Johanson KO, Huffman WF.

J Med Chem. 2000 Jan 13;43(1):22-6. No abstract available.

PMID:
10633035
12.

Idoxifene, a novel selective estrogen receptor modulator, is effective in a rat model of adjuvant-induced arthritis.

Badger AM, Blake SM, Dodds RA, Griswold DE, Swift BA, Rieman DJ, Stroup GB, Hoffman SJ, Gowen M.

J Pharmacol Exp Ther. 1999 Dec;291(3):1380-6.

PMID:
10565864
13.

Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis.

Lark MW, Stroup GB, Hwang SM, James IE, Rieman DJ, Drake FH, Bradbeer JN, Mathur A, Erhard KF, Newlander KA, Ross ST, Salyers KL, Smith BR, Miller WH, Huffman WF, Gowen M.

J Pharmacol Exp Ther. 1999 Nov;291(2):612-7.

PMID:
10525079
14.

Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model.

Miller WH, Bondinell WE, Cousins RD, Erhard KF, Jakas DR, Keenan RM, Ku TW, Newlander KA, Ross ST, Haltiwanger RC, Bradbeer J, Drake FH, Gowen M, Hoffman SJ, Hwang SM, James IE, Lark MW, Lechowska B, Rieman DJ, Stroup GB, Vasko-Moser JA, Zembryki DL, Azzarano LM, Adams PC, Huffman WF, et al.

Bioorg Med Chem Lett. 1999 Jul 5;9(13):1807-12.

PMID:
10406646
15.

Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions.

Kumar S, Hand AT, Connor JR, Dodds RA, Ryan PJ, Trill JJ, Fisher SM, Nuttall ME, Lipshutz DB, Zou C, Hwang SM, Votta BJ, James IE, Rieman DJ, Gowen M, Lee JC.

J Biol Chem. 1999 Jun 11;274(24):17123-31.

16.

Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonist with efficacy in a restenosis model.

Keenan RM, Lago MA, Miller WH, Ali FE, Cousins RD, Hall LB, Hwang SM, Jakas DR, Kwon C, Louden C, Nguyen TT, Ohlstein EH, Rieman DJ, Ross ST, Samanen JM, Smith BR, Stadel J, Takata DT, Vickery L, Yuan CC, Yue TL.

Bioorg Med Chem Lett. 1998 Nov 17;8(22):3171-6.

PMID:
9873697
17.

Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonists.

Keenan RM, Miller WH, Lago MA, Ali FE, Bondinell WE, Callahan JF, Calvo RR, Cousins RD, Hwang SM, Jakas DR, Ku TW, Kwon C, Nguyen TT, Reader VA, Rieman DJ, Ross ST, Takata DT, Uzinskas IN, Yuan CC, Smith BR.

Bioorg Med Chem Lett. 1998 Nov 17;8(22):3165-70.

PMID:
9873696
18.

A novel human bone marrow stroma-derived cell line TF274 is highly osteogenic in vitro and in vivo.

Prabhakar U, James IE, Dodds RA, Lee-Rykaczewski E, Rieman DJ, Lipshutz D, Trulli S, Jonak Z, Tan KB, Drake FH, Gowen M.

Calcif Tissue Int. 1998 Sep;63(3):214-20.

PMID:
9701625
19.

Cloning and characterization of a novel integrin beta3 subunit.

Kumar CS, James IE, Wong A, Mwangi V, Feild JA, Nuthulaganti P, Connor JR, Eichman C, Ali F, Hwang SM, Rieman DJ, Drake FH, Gowen M.

J Biol Chem. 1997 Jun 27;272(26):16390-7.

20.

Disease-modifying activity of SK&F 106615 in rat adjuvant-induced arthritis. Multiparameter analysis of disease magnetic resonance imaging and bone mineral density measurements.

Bradbeer JN, Kapadia RD, Sarkar SK, Zhao H, Stroup GB, Swift BA, Rieman DJ, Badger AM.

Arthritis Rheum. 1996 Mar;39(3):504-14.

PMID:
8607900
21.

Structure-function analysis of human transforming growth factor-alpha by site-directed mutagenesis.

Feild JA, Reid RH, Rieman DJ, Kline TP, Sathe G, Greig RG, Anzano MA.

Biochem J. 1992 Apr 1;283 ( Pt 1):91-8.

22.

Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I content.

Woessner RD, Eng WK, Hofmann GA, Rieman DJ, McCabe FL, Hertzberg RP, Mattern MR, Tan KB, Johnson RK.

Oncol Res. 1992;4(11-12):481-8.

PMID:
1338578
23.

Antagonism of TGF-alpha receptor binding and TGF-alpha induced stimulation of cell proliferation by methyl pheophorbides.

Rieman DJ, Anzano MA, Chan GW, Imburgia TJ, Chan JA, Johnson RK, Greig RG.

Oncol Res. 1992;4(4-5):193-200.

PMID:
1324032
24.

Inhibition of TGF alpha-induced second messengers by anti-EGF receptor antibody-425.

Murthy U, Rieman DJ, Rodeck U.

Biochem Biophys Res Commun. 1990 Oct 30;172(2):471-6.

PMID:
2241946
25.

Growth-inhibitory activity of interferon-beta against human colorectal carcinoma cell lines.

Wong VL, Rieman DJ, Aronson L, Dalton BJ, Greig R, Anzano MA.

Int J Cancer. 1989 Mar 15;43(3):526-30.

PMID:
2494120
26.

Synthesis and evaluation of multisubstrate inhibitors of an oncogene-encoded tyrosine-specific protein kinase. 2.

Kruse CH, Holden KG, Offen PH, Pritchard ML, Feild JA, Rieman DJ, Bender PE, Ferguson B, Greig RG, Poste G.

J Med Chem. 1988 Sep;31(9):1768-72.

PMID:
3045321
27.

Synthesis and evaluation of multisubstrate inhibitors of an oncogene-encoded tyrosine-specific protein kinase. 1.

Kruse CH, Holden KG, Pritchard ML, Feild JA, Rieman DJ, Greig RG, Poste G.

J Med Chem. 1988 Sep;31(9):1762-7.

PMID:
2970550
28.

Supplemental Content

Loading ...
Support Center